Ibsa Pharma recalls
Ibsa Pharma appears in 15 official U.S. recall notices indexed by RecallRadar, most recently on 2023-03-01.
Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.
- TIROSINT - SOL (levothyroxine sodium) Oral Solution, 50 microgram/mL
FDA Drug · Class II · 2023-03-01 · Ibsa Pharma - TIROSINT - SOL (levothyroxine sodium) Oral Solution, 112 microgram/mL
FDA Drug · Class II · 2023-03-01 · Ibsa Pharma - TIROSINT - SOL (levothyroxine sodium) Oral Solution, 75 microgram/mL
FDA Drug · Class II · 2023-03-01 · Ibsa Pharma - TIROSINT - SOL (levothyroxine sodium) Oral Solution, 88 microgram/mL
FDA Drug · Class II · 2023-03-01 · Ibsa Pharma - TIROSINT - SOL (levothyroxine sodium) Oral Solution, 44 microgram/mL
FDA Drug · Class II · 2023-03-01 · Ibsa Pharma - TIROSINT - SOL (levothyroxine sodium) Oral Solution, 175 microgram/mL
FDA Drug · Class II · 2023-03-01 · Ibsa Pharma - TIROSINT - SOL (levothyroxine sodium) Oral Solution, 25 microgram/mL
FDA Drug · Class II · 2023-03-01 · Ibsa Pharma - TIROSINT - SOL (levothyroxine sodium) Oral Solution, 137 microgram/mL
FDA Drug · Class II · 2023-03-01 · Ibsa Pharma - TIROSINT - SOL (levothyroxine sodium) Oral Solution, 150 microgram/mL
FDA Drug · Class II · 2023-03-01 · Ibsa Pharma - TIROSINT - SOL (levothyroxine sodium) Oral Solution, 200 microgram/mL
FDA Drug · Class II · 2023-03-01 · Ibsa Pharma - TIROSINT - SOL (levothyroxine sodium) Oral Solution, 100 microgram/mL
FDA Drug · Class II · 2023-03-01 · Ibsa Pharma - TIROSINT - SOL (levothyroxine sodium) Oral Solution, 62.5 microgram/mL
FDA Drug · Class II · 2023-03-01 · Ibsa Pharma - TIROSINT - SOL (levothyroxine sodium) Oral Solution, 125 microgram/mL
FDA Drug · Class II · 2023-03-01 · Ibsa Pharma - TIROSINT - SOL (levothyroxine sodium) Oral Solution, 37.5 microgram/mL
FDA Drug · Class II · 2023-03-01 · Ibsa Pharma - TIROSINT - SOL (levothyroxine sodium) Oral Solution, 13 microgram/mL
FDA Drug · Class II · 2023-03-01 · Ibsa Pharma